4
Changes in Ownership
PROCEPT BioRobotics Corp Filed Acc 0001628280-24-004120
EVP, CFO sold 29,581 shares at an average $50.09 ($1,481,579)
- EVP, CFO acquired 29,581 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waters Kevin EVP, CFO | 2024-02-07 | Option exercise 10b5-1 | +904 | $4.52 | $4,086 | 34,427 | D |
| Waters Kevin EVP, CFO | 2024-02-07 | Sale 10b5-1 | −904 | $50.00 | $45,200 | 33,523 | D |
| Waters Kevin EVP, CFO | 2024-02-09 | Option exercise 10b5-1 | +28,677 | $4.52 | $129,620 | 62,200 | D |
| Waters Kevin EVP, CFO | 2024-02-09 | Sale 10b5-1 | −28,677 | $50.09 | $1,436,379 | 33,523 | D |
| Derivatives | |||||||
| Waters Kevin EVP, CFO | 2024-02-07 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −904 | 102,953 | D | ||
| Waters Kevin EVP, CFO | 2024-02-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −28,677 | 74,276 | D | ||
| Open-market sales · 29,581 sh · avg $50.09 · $1,481,579 | |||||||
Loading xslF345X05/wk-form4_1707516534.xml…